State Of Wyoming Revolution Medicines, Inc. Transaction History

State Of Wyoming

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$14.54 - $27.17 $58 - $108	4 Added 26.67%	19 $0
Q1 2022 May 13, 2022	BUY	$17.31 - $26.4 $51 - $79	3 Added 25.0%	15 $0
Q4 2021 Feb 11, 2022	SELL	$24.35 - $33.7 $24 - $33	-1 Reduced 7.69%	12 $0
Q3 2021 Feb 11, 2022	SELL	$23.95 - $33.41 $143 - $200	-6 Reduced 31.58%	13 $0
Q2 2021 Feb 11, 2022	BUY	$29.0 - $47.44 $551 - $901	19 New	19 $1,000

266

161M

260K

620K

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $3.8B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

Get notified when there are updates to the investment portfolio of State Of Wyoming, based on Form 13F filings with the SEC.

Stay updated on State Of Wyoming with notifications on news.